Dr. Nicholas Wayne Clavin, MD

Dr. Clavin practices at Atrium Health Transplant Center - Kidney - HOPD in Charlotte, North Carolina.

Dr. Clavin's NPI, 1225232747, was assigned on June 11, 2007. Dr. Clavin graduated from SUNY Upstate Medical University in 2003. Dr. Clavin holds North Carolina license 2013-01500.

Dr. Clavin's primary practice is Atrium Health Transplant Center - Kidney - HOPD, at 1025 Morehead Medical Dr, Charlotte, NC 28204.

Dr. Clavin's primary practice is Atrium Health Transplant Center - Kidney - HOPD in Charlotte, North Carolina. Dr. Clavin is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Atrium Health Levine Children's Gastroenterology. Dmand AI also links Dr. Clavin to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Clavin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clavin practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Clavin's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Clavin is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Clavin's licenses on file in 3 states: North Carolina, California and New York.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Clavin treats.

CMS data shows 61 Medicare services from Dr. Clavin across 2 procedure codes in 2024, all of them office visits, for 52 Medicare patients. Medicare paid $4,224 for them.

CMS counts 52 Medicare patients who saw Dr. Clavin in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have cancer, and 67% have high cholesterol. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Clavin's median patient age at 53, with 96% women.

In 2024, Dr. Clavin wrote 29 Medicare Part D claims for 13 patients. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Clavin for performance year 2024, reported through an alternative payment model (APM). Dr. Clavin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clavin as offering telehealth. CMS counts 27 procedures of mastectomy by Dr. Clavin, more than 84% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Clavin, published from 2014 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Cell Differentiation, Cell Proliferation and Mesenchymal Stem Cells. Dr. Clavin has published most often in Plast Reconstr Surg. Dr. Clavin's most frequent co-authors are Babak J. Mehrara, MD, Marc A. Soares, MD and Joseph J. Disa, MD.

CMS Open Payments shows 685 general payments to Dr. Clavin from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Abbvie Inc. paid the most, $320,007. It also lists 1 research payment totaling $10,500 in 2021.

Dmand AI lists 1 award for Dr. Clavin, most recently CMS Stage 1 EHR in 2013.

Dr. Clavin graduated from SUNY Upstate Medical University in 2003.

Dr. Clavin is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.